Harbour Investments’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

Harbour Investments’s Portfolio PILL Stock Details PILL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$14	–	3695
2025 Q1	$14	Hold	2	–	–	﹤0.01%	3530
2024 Q4	$14	Buy	+2	New	+$17	﹤0.01%	3464

Other funds holding PILL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Investments's PILL Position: Q2 2025 in Review

Harbour Investments sold out of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) in Q2 2025, closing a stake of 2 shares — an estimated $14 sold.

Harbour Investments first reported a position in PILL in Q4 2024 and held it in 2 quarters. The position peaked at $14 in Q1 2025. 5 funds tracked by Wall St. Rank hold PILL as of Q2 2025.

Harbour Investments reported no remaining Direxion Daily Pharmaceutical & Medical Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
Harbour Investments sold 2 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q2 2025, an estimated $14.
Harbour Investments first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q4 2024 and held it in 2 quarters.
Harbour Investments's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $14 in Q1 2025.
5 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q2 2025.

Based on Harbour Investments's 13F filing for Q2 2025, filed 28 Jul 2025.